Stockscreener 앱 받기
0.272
0.74%
0.002
전일 마감가:
$0.27
열려 있는:
$0.265
하루 거래량:
35,986
Relative Volume:
0.23
시가총액:
$2.69M
수익:
$24,000
순이익/손실:
$-78.06M
주가수익비율:
-0.00938
EPS:
-28.9956
순현금흐름:
$-21.81M
1주 성능:
-6.14%
1개월 성능:
-15.42%
6개월 성능:
-44.61%
1년 성능:
-95.14%
1일 변동 폭
$0.2605
$0.2806
1주일 범위
$0.2605
$0.292
52주 변동 폭
$0.24
$8.40
Catheter Precision Inc. Stock (VTAK) Company Profile
명칭
Catheter Precision Inc.
전화
973 691 2000
주소
1670 Highway 160 West, Suite 205, Fort Mill
VTAK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VTAK
Catheter Precision Inc.
|
0.279 | 2.69M | 24,000 | -78.06M | -21.81M | -29.00 |
|
ABT
Abbott Laboratories
|
132.26 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.50 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.31 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.41 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.42 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Catheter Precision Inc. Stock (VTAK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-08-13 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2018-11-02 | 개시 | Maxim Group | Buy |
Catheter Precision Inc. 주식(VTAK)의 최신 뉴스
Catheter Precision (VTAK) Reveals Enhanced Clinical Data on VIVO System | VTAK Stock News - GuruFocus
New Clinical Data Presented about VIVO at the 46th Annual Heart Rhythm Association Conference - The Manila Times
Catheter Precision Inc [VTAK] Director makes an insider purchase of 3 shares worth 1.0. - knoxdaily.com
Catheter Precision to Attend and Participate in the 46th Heart R - GuruFocus
Catheter Precision to Attend and Participate in the 46th Heart Rhythm Society | VTAK Stock News - GuruFocus
Catheter Precision to Attend and Participate in the 46th Heart Rhythm Society - The Manila Times
Breakthrough Cardiac Study: Catheter Precision's VIVO System Achieves 94% Accuracy in European Multi-Center Trial - Stock Titan
Catheter Precision to acquire late-stage heart failure treatment assets in development - MSN
Analytical Lens: Exploring Catheter Precision Inc (VTAK)’s Financial Story Through Ratios - DWinneX
Catheter Precision Inc (VTAK) Stock: A Year of Highs and Lows in the Market - investchronicle.com
Can Catheter Precision Inc (VTAK) meet market expectations this quarter? - uspostnews.com
How analysts predict Five9 Inc (FIVN) will perform this quarter? - uspostnews.com
Catheter Precision (VTAK) Acquires Assets for Cardiac Technology Expansion | VTAK Stock News - GuruFocus
Catheter Precision to acquire assets of Cardionomic related to CPNS system - TipRanks
Catheter Precision to Acquire Assets in Development for Late-Stage Treatment for Acute Decompensated Heart Failure - The Manila Times
Catheter Precision To Acquire Assets In Development For Late-Stage Treatment For Acute Decompensated Heart Failure - marketscreener.com
Breakthrough Heart Failure Treatment Tech With 1M Patient Potential Acquired: Early Clinical Success Revealed - Stock Titan
Catheter Precision Reports 'Going Concern' Notice in Recent Annual Report - marketscreener.com
Catheter Precision Makes NYSE American Section 610(b) Public Announcement - The Manila Times
Catheter Precision Makes NYSE American Section 610(b) Public Announcement | VTAK Stock News - GuruFocus
Catheter Precision, Inc. Announces Receipt of Audit Opinion with Going Concern Doubt - Nasdaq
Crude Oil Gains a Dollar Off China-U.S. Optimism, U.S. EIA Data - The Globe and Mail
Tariff-Driven Volatility Impacting Wall Street Trading Desks - The Globe and Mail
Too Quiet? AI Chip Curbs Ignite Selling—Can Bulls Bounce Back? - The Globe and Mail
Slate Grocery REIT Announces Distribution for the Month of April 2025 - The Globe and Mail
Catheter Precision (VTAK) Secures US Patent for Surgical Closure Device | VTAK Stock News - GuruFocus
Catheter Precision, Inc. Receives Notice of First Patent Allowance in the US for LockeT Product Line - GlobeNewswire
Lachine Hospital Foundation Gala raises $406,500 to support the modernization of Lachine Hospital - The Manila Times
Major Patent Win: Catheter Precision's LockeT Device Gets US Protection Amid Global Expansion - Stock Titan
S&P 500 loses 5%, more than half its prior historic gain, after White House clarifies US is tariffing China at 145% - The Globe and Mail
Tesla Stock’s (TSLA) Tariff Surge Turns Into a Skid - The Globe and Mail
VTAK stock touches 52-week low at $0.3 amid market challenges - Investing.com
VTAK stock touches 52-week low at $0.3 amid market challenges By Investing.com - Investing.com South Africa
Catheter Precision Inc. (VTAK) reports earnings - Quartz
Catheter Precision Q4 2024 revenue jumps 55% to USD 149K - Medical Buyer
Catheter Precision, Inc. Announces Fourth Quarter and Full Year 2024 Update and Financial Results - GlobeNewswire
Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure - The Manila Times
Catheter Precision Reports 55% Revenue Jump as LockeT Adoption Accelerates - Stock Titan
Catheter Precision to Participate in and Share Data at Upcoming Industry Conferences - The Manila Times
Imperative Care Expands Precision Thrombectomy Portfolio - Diagnostic and Interventional Cardiology
Imperative Care Expands Symphony Precision Thrombectomy Portfolio with Purpose-Built Design for the Treatment of Venous Thrombosis - Business Wire
VTAK stock touches 52-week low at $0.31 amid market challenges - Investing.com Australia
VTAK stock touches 52-week low at $0.31 amid market challenges By Investing.com - Investing.com South Africa
Global 3D Cardiac Mapping System Market To Reach $2.73 Billion By 2029 With A Growth Rate Of 9.6% As Reveal... - WhaTech
3D Cardiac Mapping System Market To Reach $2.73 Billion By 2029 With A Growth Rate Of 9.6% - WhaTech
Catheter Precision to Attend and Participate in the Western Atrial Fibrillation Symposium - The Manila Times
Catheter Precision's LockeT Innovation Takes Center Stage at Elite AF Symposium - StockTitan
Ra Medical : Reports First Quarter 2019 Financial Results -May 13, 2019 at 04:07 pm EDT - Marketscreener.com
Global Magnetic Ablation Catheters Market Poised for Significant Growth, Projected to Reach USD 1,114.4 Million by 2035 Driven by Technological Advancements and Rising Cardiovascular Cases | Future Market Insights, Inc. - GlobeNewswire
Catheter Precision Inc. Engages PCG Advisory to Broaden Investor Relations Strategy - The Manila Times
ACT-ion Raises $7.5 million in Pre-Series A Round Led by BASF Venture Capital - The Manila Times
Catheter Precision Inc. (VTAK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10.11%
0.04%
자본화:
|
볼륨(24시간):